Skip to main content
. 2022 Apr 2;11:100249. doi: 10.1016/j.lana.2022.100249

Table 2.

Odds ratio (95% confidence intervals) of use of obesogenic medications by socioeconomic status, NHANES 2009-2018.

Unweighted N Prevalence (95% CI), % Odds ratio (95% confidence interval)
Crude Model 1 Model 2
Composite SES
 Low 4737 44.8 (42.6, 46.9) 1.7 (1.5, 1.9) 1.5 (1.4, 1.8) 1.3 (1.2, 1.5)
 Intermediate 2677 45.6 (43.3, 47.9) 1.8 (1.6, 2.0) 1.2 (1.03,1.4) 1.1 (0.96, 1.3)
 High 3259 32.3 (30.6, 34.0) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref)
Education
 <High school 2455 45.9 (43.0, 48.9) 2.0 (1.7, 2.3) 1.4 (1.2, 1.7) 1.2 (1.02, 1.4)
 High school graduate 2452 41.4 (38.7, 44.1) 1.7 (1.4, 2.0) 1.4 (1.2, 1.7) 1.2 (0.99, 1.4)
 Some college 3378 38.8 (36.3, 41.2) 1.5 (1.3, 1.7) 1.3 (1.1, 1.6) 1.2 (1.01, 1.5)
 College graduate or above 2388 29.8 (27.6, 32.1) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref)
Household income
 Below poverty level 2127 46.4 (43.6, 49.1) 1.5 (1.3, 1.7) 1.3 (1.1, 1.5) 1.2 (1.04, 1.4)
 Equal or above poverty level 8546 36.5 (35.1, 38.8) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref)
Insurance type
 No insurance 1146 34.1 (30.4, 37.8) 1.0 (0.9, 1.2) 1.6 (1.4, 1.9) 1.4 (1.2, 1.7)
 Public insurance only 3789 50.0 (47.6, 51.8) 2.0 (1.7, 2.2) 1.3 (1.1, 1.4) 1.2 (1.02, 1.3)
 Private insurance 5738 33.3 (31.6, 35.0) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref)

Model 1 adjusted for age, sex, race/ethnicity, and number of prescription medications.

Model 2 further adjusted for diabetes, depression, hypertension, cardiovascular disease, and arthritis.